STAAR Surgical Company
STAA
NASDAQ·Healthcare·Medical - Instruments & Supplies·Mkt cap $1.2B
$23.47
▼ -0.45%
P/E
293.38
Mkt Cap
$1.2B
52-Wk Range
$15.59–$35.87
52-Week Range
$15.59 - $35.87
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 15.2% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary Collamer material technology with biocompatible, UV-blocking properties
- Reversible vision correction solution differentiating ICL from permanent laser procedures
- Established global distribution network with direct sales presence in key markets
- Comprehensive product portfolio addressing multiple refractive errors with single platform
Bear Case
2 risks
- Average volatility.
- Extreme premium - high expectations embedded
Growth
Stable outlook
Rising global myopia prevalence, particularly in Asia-Pacific markets with high population density
Value
Extreme premium - high expectations embedded
Momentum
Falling
-21.7% over 3m
Quality
Excellent
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying STAA right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 4, 2026
AUG 12, 2026
Reported EPS of $0.16 vs $0.22 consensus (-27.7% surprise). Revenue of $93.5M vs $90.6M expected (+3.2%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-27.7%
Revenue trend · last 8Q
—
-36%
-45%
-55%
+7%
+18%
+120%
+111%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 26
Q1 26
Q2 26
$88.6M
$49.0M
$42.6M
$44.3M
$94.7M
$57.8M
$93.5M
$93.5M
Margins · last 8Q
Gross
74.5%
Operating
10.8%
Profit
8.6%
Wall Street consensus
7 analysts · 29% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
29%
Hold
71%
Sell
0%
Median Price Target
—
Latest: Jefferies · Aug 13, 2026
vs Industry
How STAA stacks vs Medical - Instruments & Supplies
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related